Sign inGet started

Paulsen Gisela

Insider CIK 1807104 · EXAS Gen Mgr, Precision Oncology · OCX President & COO

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
OCX Oncocyte Corp D To issuer deriv2022-12-162022-12-20171,875— $0203,125SEC↗
OCX Oncocyte Corp D To issuer deriv2022-12-162022-12-20125,000— $00SEC↗
OCX Oncocyte Corp D To issuer deriv2022-12-162022-12-2070,313— $054,687SEC↗
OCX Oncocyte Corp D To issuer2022-12-012022-12-20175,000— $0366,500SEC↗
OCX Oncocyte Corp A Award2022-08-152022-08-17175,000— $0191,500SEC↗
OCX Oncocyte Corp A Award2022-08-152022-08-17350,000— $0541,500SEC↗
OCX Oncocyte Corp P Buy2022-03-172022-03-1716,500$1.20 $19.8K16,500SEC↗
OCX Oncocyte Corp A Award deriv2022-03-152022-03-17125,000— $0125,000SEC↗
OCX Oncocyte Corp A Award deriv2022-03-152022-03-17125,000— $0125,000SEC↗
EXAS EXACT SCIENCES CORP A Award deriv2020-04-202020-04-2266,267— $066,267SEC↗